Patents-Review.com
🔗 Permalink
Assignee profile:

ERYTECH PHARMA

City:

Lyons

Country:

France

Published Applications:

17

Last publication date:

2024-01-25

Patent Grants:

17

Last grant date:

2025-04-22

Top Inventors for applications by ERYTECH PHARMA

These are the the leading inventors for applications assigned to ERYTECH PHARMA:

Recent patent applications by ERYTECH PHARMA

ERYTECH PHARMA based in Lyons, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-01-25 ✅ Patent 12,280,080 granted on 2025-04-22
US20240024391A1
Human necessities

Antibacterial composition and uses thereof

 #2 | 2021-03-04 ✅ Patent 11,957,724 granted on 2024-04-16
US20210060100A1
Human necessities

Phage therapy of infections

 #3 | 2021-01-14 ✅ Patent 11,458,170 granted on 2022-10-04
US20210008114A1
Human necessities

Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor

 #4 | 2020-08-13 ✅ Patent 11,273,210 granted on 2022-03-15
US20200254074A1
Human necessities

Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency

 #5 | 2019-01-03 ✅ Patent 11,141,468 granted on 2021-10-12
US20190000941A1
Human necessities

Method of treating a mammal, including human, against cancer using methionine and asparagine depletion

 #6 | 2018-12-06 ✅ Patent 10,780,151 granted on 2020-09-22
US20180344822A1
Human necessities

Composition and therapeutic anti-tumour vaccine

 #7 | 2018-12-06 ✅ Patent 10,780,126 granted on 2020-09-22
US20180344771A1
Human necessities

Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor

 #8 | 2016-11-10 ✅ Patent 9,950,049 granted on 2018-04-24
US20160324946A1
Human necessities

Composition and therapeutic anti-tumour vaccine

 #9 | 2016-04-07 ✅ Patent 10,286,008 granted on 2019-05-14
US20160095884A1
Human necessities

Method for stabilising suspensions of red blood cells encapsulating an active ingredient

 #10 | 2016-02-04 ✅ Patent 9,968,663 granted on 2018-05-15
US20160030532A1
Human necessities

Erythrocytes containing arginine deiminase

 #11 | 2015-03-12 ✅ Patent 9,580,739 granted on 2017-02-28
US20150071894A1
Chemistry; metallurgy

Test for predicting neutralization of asparaginase activity

 #12 | 2014-06-05 ✅ Patent 10,273,444 granted on 2019-04-30
US20140154797A1
Chemistry; metallurgy

Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes

 #13 | 2012-05-17 ✅ Patent 8,852,880 granted on 2014-10-07
US20120121570A1
Chemistry; metallurgy

Test for predicting neutralization of asparaginase activity

 #14 | 2012-01-12 ✅ Patent 9,364,504 granted on 2016-06-14
US20120009140A1
Human necessities

Compostition and therapeutic anti-tumour vaccine

 #15 | 2010-12-09 ✅ Patent 8,974,802 granted on 2015-03-10
US20100310612A1
Human necessities

Medicament for the treatment of cancer of the pancreas

 #16 | 2008-11-06 ✅ Patent 9,125,876 granted on 2015-09-08
US20080274092A1
Human necessities

Erythrocytes containing arginine deiminase

 #17 | 2008-10-23 ✅ Patent 8,617,840 granted on 2013-12-31
US20080261262A1
Chemistry; metallurgy

Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes

Also check out ERYTECH PHARMA's (Lyons, France) applicant profile with 12 patent applications submitted.

AssigneeID:

374200 ⎘